CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 99 enrolled
Drug / intervention
probe based laser endomicroscopy (pCLE)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01793246
NCT01793246N/ACompleted

Registry Trial to Determine pCLE Image Interpretation Criteria and Preliminary Accuracy: Discrete Pulmonary Lesions and Acute Rejection in Transplanted Lungs

Mauna Kea Technologies·observational·Posted Feb 15, 2013·Updated Aug 29, 2017

In Brief

An observational study evaluating probe based laser endomicroscopy (pCLE) for Lung Neoplasms and Disorder Related to Lung Transplantation. Completed, enrolled 99 participants across 9 sites.

Detailed Summary

Patients will be enrolled that are undergoing bronchoscopy for diagnosis of discrete lung lesions or for detection of acute rejection following lung transplants. The hypothesis is that bronchoscopy together with probe-based endomicroscopy (pCLE)results in improved and/or incremental diagnostic yield (definitive diagnosis) over conventional bronchoscopy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedFeb 15, 2013
Enrollment StartFeb 1, 2013
Primary CompletionDec 24, 2016
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 13.4 years ago

Interventions

probe based laser endomicroscopy (pCLE)device

pCLE will be added to standard bronchoscopy for the purpose of characterizing lung cancer or for characterizing of acute rejection in transplanted lungs.